Investing Ideas
/
South African Pharmaceuticals & Biotech Healthy potentially undervalued

South African Pharmaceuticals & Biotech Healthy potentially undervalued

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are potentially undervalued and in an acceptable financial position.

1 companies

Aspen Pharmacare Holdings

Market Cap: R65.3b

Operates as a specialty and branded pharmaceutical company in Africa, the Middle East, Europe, CIS, Australasia, Asia, and the Americas.

APN

R147.04

4.6%

46.6%